Non-myeloablative allogeneic hematopoietic transplantation and induction of graft-versus-malignancy.
作者信息
Khouri Issa, Giralt Sergio, Champlin Richard
机构信息
M.D. Anderson Cancer Center, 1515 Holcombe Blvd, Box 65, Houston, TX 77030-4095, USA.
出版信息
Cancer Treat Res. 2002;110:137-47. doi: 10.1007/978-1-4615-0919-6_7.
PMID:11908196
Abstract
摘要
相似文献
1
Non-myeloablative allogeneic hematopoietic transplantation and induction of graft-versus-malignancy.非清髓性异基因造血移植与移植物抗恶性肿瘤效应的诱导
Cancer Treat Res. 2002;110:137-47. doi: 10.1007/978-1-4615-0919-6_7.
2
Allogeneic hematopoietic cell transplantation without myeloablative conditioning for patients with advanced hematologic malignancies.对晚期血液系统恶性肿瘤患者进行非清髓性预处理的异基因造血细胞移植。
Cytotherapy. 2001;3(4):253-60. doi: 10.1080/146532401317070880.
3
Reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia.减低强度预处理及异基因造血干细胞移植治疗急性髓系白血病
Expert Rev Anticancer Ther. 2008 May;8(5):785-98. doi: 10.1586/14737140.8.5.785.
4
Full-intensity and reduced-intensity allogeneic stem cell transplantation in AML.急性髓系白血病的全强度和降低强度异基因干细胞移植
Bone Marrow Transplant. 2008 Mar;41(5):415-23. doi: 10.1038/sj.bmt.1705975. Epub 2008 Jan 21.
5
Allogeneic haemopoietic stem cell transplantation using non-myeloablative conditioning--a local experience.采用非清髓性预处理的异基因造血干细胞移植——一项本地经验。
Med J Malaysia. 2003 Jun;58(2):229-35.
6
Conditioning regimens for allogeneic hematopoietic stem cell transplants in acute myeloid leukemia.异基因造血干细胞移植治疗急性髓系白血病的预处理方案。
Bone Marrow Transplant. 2017 Nov;52(11):1504-1511. doi: 10.1038/bmt.2017.83. Epub 2017 May 15.
7
Treatment of lymphoid malignancies with non-myeloablative stem cell transplantation.非清髓性干细胞移植治疗淋巴系统恶性肿瘤
Hematology. 2002 Jun;7(3):151-5. doi: 10.1080/1024533021000008209.
8
Allogeneic hematopoietic stem cell transplantation (HSCT) after reduced intensity conditioning.减低剂量预处理后的异基因造血干细胞移植（HSCT）
Transfus Apher Sci. 2011 Apr;44(2):205-10. doi: 10.1016/j.transci.2011.01.019. Epub 2011 Feb 22.
9
Comparison of Outcomes for Pediatric Patients With Acute Myeloid Leukemia in Remission and Undergoing Allogeneic Hematopoietic Cell Transplantation With Myeloablative Conditioning Regimens Based on Either Intravenous Busulfan or Total Body Irradiation: A Report From the Japanese Society for Hematopoietic Cell Transplantation.基于静脉注射白消安或全身照射的清髓性预处理方案对急性髓系白血病缓解期并接受异基因造血细胞移植的儿科患者的结局比较：来自日本造血细胞移植学会的报告
Biol Blood Marrow Transplant. 2015 Dec;21(12):2141-2147. doi: 10.1016/j.bbmt.2015.08.011. Epub 2015 Aug 10.
10
Time-to-Event Ratio to Predict Outcome in Patients with Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation?用于预测接受异基因造血细胞移植的急性髓系白血病患者预后的事件发生时间比？
Biol Blood Marrow Transplant. 2017 Oct;23(10):1804-1808. doi: 10.1016/j.bbmt.2017.06.016. Epub 2017 Jul 5.
引用本文的文献
1
Phase II study of gonadotropin-releasing hormone analog for ovarian function preservation in hematopoietic stem cell transplantation patients.促性腺激素释放激素类似物在造血干细胞移植患者卵巢功能保护中的 II 期研究。
Oncologist. 2012;17(2):233-8. doi: 10.1634/theoncologist.2011-0205. Epub 2012 Jan 26.
Zotero 插件